Saint Francis Care: against COVID-19 Hospital

Project: Convalescent Plasma in the Treatment of COVID 19

Summary: The purpose of this study is to collect blood from previously COVID-19 infected persons who have recovered and use it as a treatment for those who are currently sick with a severe or life-threatening COVID-19 infection.

Conditions: sars-cov-2, covid, coronavirus
Primary purpose: Treatment
Treatment: Convalescent plasma
Phase: Phase 2
Start date: April 2020
End date: December 2020
Trial size: 15 participants
Overall contact: Latha Dulipsingh
Technology: COVID Labs/Universities
Industry: COVID R&D
Headquarters: United Kingdom
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership